Research Colloquium
Call for Abstracts!
8th Annual Research Colloquium
Friday, October 2, 2026
The UTRGV School of Medicine is pleased to announce this call for abstracts for the 2026 Research Colloquium to be held on Friday October 2, 2026! The Colloquium’s purpose is to highlight medical research conducted by SOM students, residents, fellows, postdocs, faculty, and staff, and UTRGV students collaborating with SOM labs and/or departments.
Questions? Email us at jorge.teniente@utrgv.edu
Call for Abstracts!
The Colloquium is an opportunity to highlight and present your research (e.g. case reports, QI/QA, lab research, retrospective data analyses or other scholarly work) to expand scientific and professional knowledge.
Abstracts must meet all the following requirements for acceptance by the published deadline. Submissions that do not meet these criteria will not be considered. No supporting documentation will be accepted after the submission deadline.
- Abstracts must present results. In general, results are defined as quantitative or clearly verifiable qualitative findings that directly answer the study objective, derived from analyzed data.
- Abstracts must provide details on regulatory clearance (IRB/IACUC) in the methods section. When applicable, the IRB/IACUC number and/or IRB/IACUC determination letter must be submitted.
- Abstracts from trainees (medical, undergraduate, graduate students and residents) must identify a faculty mentor. Trainees should obtain approval from their faculty mentor prior to submission.
Additional abstract submission guidelines:
- No more than 3 submissions per individual will be accepted.
- Presenters must be able to attend in person. Registration is required to confirm oral and/or poster presentations.
- A limited number of abstracts will be selected for oral presentations with priority given to new research/clinical abstracts.
Submissions will undergo peer review by the Colloquium’s Faculty Review committee. Ratings will be based on the overall quality of the abstract. In addition, as determined by the Scientific Committee, a limited number of abstracts will be selected for oral presentations with priority given to new research/clinical abstracts. The Committee’s decision is final.
All abstracts must be submitted by 11:59 PM on Friday July 31, 2026.
Upon submission of abstract, the submission portal will display confirmation of your submission. After the review and selection process, Notification of Abstract Approval will occur on Friday August 21, 2026, via direct email notification. To submit an abstract, click the Submit Abstract button below. If you have any questions, please contact us at jorge.teniente@utrgv.edu.
Abstract Formats
Abstracts may be research/clinical focused, program focused, or case reports. They should be no longer than one 8.5” by 11” page, in Arial 11 font, margins no smaller than one inch, may be single space and no more than 350 words. Please list the title of abstract, all authors/presenters by full first name then last name, and affiliations. If applicable, please submit an approval letter of your IRB protocol and/or QI/QA project. Please minimize the use of abbreviations and do not cite reference in the abstract.
NOTE: An abstract is a short summary of your completed research. Do not submit final oral or poster presentations.
Structured abstracts are required and should include four simple headings: Background, Methods, Results and Conclusions.
- Background should include a statement that identifies why this is an important topic and specifies the purpose or goal of the study.
- Include a description of the Methods used to consider setting, population, sampling techniques, measures, and analytical procedures. Clinically focused abstracts may also include a case description or barriers encountered in application of evidence to practice. Ensure regulatory processes (as applicable) are mentioned.
- A summary of the Results should be included, presented in sufficient detail to support the conclusions.
- Please include a statement of the Conclusions It is recommended that clinically focused abstracts convey practical applications of their findings.
Structured abstracts are required and should include four simple headings: Purpose, Description, Partners and Looking Ahead.
- Purpose should note the purpose and intent of the program and how it promotes health equity and/or eliminates disparities.
- Description should include a brief outline of the program, its scope, target population for services, lessons learned, and a summary of outcomes.
- In Partners, please mention collaborative stakeholders and community partners and their roles.
- Lastly, in Looking Ahead, provide an overview of the program benefits/impact on community and if applicable the program’s next steps.
Structured abstracts are required and should include three simple headings: Background, Case Presentation, and Conclusions.
- Background should state why the case should be reported and its novelty.
- Case presentation provides a brief description of the patient’s clinical and demographic details, the diagnosis, any interventions, and the outcomes.
- In Conclusions, please provide a brief summary of the clinical impact or potential implications of the case report.
Please note that your Abstract Submission is not registration to the Colloquium. Registration for the Colloquium will be done separately via a Forms link to be released on Monday August 24, 2026. For more information, email us at jorge.teniente@utrgv.edu.
To submit abstract using the buttons below, first complete the submission form and then upload your file.
Guidelines & Templates
Timeline
|
Announcements Timeline |
|---|
MAY 2026
JULY 2026 Abstract Submission DEADLINE! AUGUST 2026
SEPTEMBER 2026 Final Orals and Posters DUE! (Only posters submitted by this date will be forwarded for printing by SOM Aaronson Library). Any poster not submitted by this deadline will be the author’s responsibility to print.
OCTOBER 2026
|
Agenda
|
Research Colloquium Agenda |
|---|
|
The Agenda will be provided to all participants Monday, September 21, 2026. |